Please login to the form below

Not currently logged in
Email:
Password:

AndroGel

This page shows the latest AndroGel news and features for those working in and with pharma, biotech and healthcare.

AbbVie sales jump on strong Humira gains

AbbVie sales jump on strong Humira gains

Among other products, HIV therapy Kaletra (lopinavir/ ritonavir) rose 1.1 per cent to $278m, while revenue from testosterone replacement therapy AndroGel fell 6.5 per cent to $258m.

Latest news

More from news
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest Intelligence

  • Pharma deals in May 2015 Pharma deals in May 2015

    This is not the first such case for Teva, as the FTC also filed suit last September for an alleged pay for delay relating to AndroGel.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OUTiCO

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...

Latest intelligence

The ALS patient journey
Nick Goldup is the Director of Care Improvement at the Motor Neuron Disease Association (MNDA). Here, he offers his insights into the journey for patients with ALS and explores the...
Equipping your medical affairs teams with solutions to navigate the healthcare landscape
Dr Tyler Ray, OPEN Health Medical Communications...
Protein degraders
Can protein degraders unlock ‘undruggable’ drug targets?
Exploring a new and exciting area of small-molecule drug discovery...

Infographics